Evidence map›Paper›PMID 31752611›Full record

ReviewStroke2020

Genetics of Cerebral Small Vessel Disease.

Sandro Marini, Christopher D Anderson, Jonathan Rosand

Abstract readReview
In one paragraph

Review in Stroke, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Review
  2. Unravelling the genetic architecture of cerebral small vessel disease in the context of stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  3. Promoter hypomethylation ofFrontiers in genetics · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sandro MariniFrom the Center for Genomic Medicine (S.M., C.D.A., J.R.), Massachusetts General Hospital, Boston.
Christopher D AndersonFrom the Center for Genomic Medicine (S.M., C.D.A., J.R.), Massachusetts General Hospital, Boston.
Jonathan RosandFrom the Center for Genomic Medicine (S.M., C.D.A., J.R.), Massachusetts General Hospital, Boston.

Funding

Recurrent Hemorrhagic Stroke in Minority PopulationsR01NS093870 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI JONATHAN ROSAND, Amytis Towfighi · 2016 to 2026
$12.3M
Sequencing Annotation and Functional Analysis in Risk of Intracerebral HemorrhageR01NS103924 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID · 2018 to 2022
$3.4M
Genetic Analyses of Lipids in Cerebral Hemorrhage and Small Vessel DiseaseK23NS086873 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID · 2014 to 2018
$951k
American Heart Association-American Stroke Association 18POST34080063NINDS NIH HHS K23 NS086873NINDS NIH HHS R01 NS093870NINDS NIH HHS R01 NS103924
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArteriolosclerosisCerebral Small Vessel DiseasesHumansIschemiaMagnetic Resonance ImagingMutationStrokeamyloidosisarteriolosclerosescerebral small vessel diseasesgeneticsgenome-wide association studiesneuroimaging

Identifiers

PMID31752611
PMCPMC7337039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.